Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Med ; 46(6): 1951-1957, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33125502

RESUMEN

Curcumin has been used since ancient times as a treatment for a wide range of pathologies. For centuries, it has been considered to be an effective aid for common human diseases. Curcuma longa has been reported to possess various beneficial properties and actions, including anti­inflammatory, proapoptotic, antiangiogenic and cortisone­like actions. Pterygium is a degenerative disorder of the conjunctiva indicative of a strong inflammatory condition that requires surgical treatment, which often results in disfiguring sclerocorneal scars. The delay in the healing of superficial corneal wounds caused by topical administration of light­cortisone results in improved restoration of corneal functions and anatomy compared with physiological healing processes. The present review is focused on the medicinal properties of curcumin, the main component of Curcuma longa extract, in particular its strong cortisone­like effect, and its potential use for the prevention and treatment of sclerocorneal scars resulting from pterygium surgical excision.


Asunto(s)
Cicatriz/tratamiento farmacológico , Cicatriz/etiología , Lesiones de la Cornea/tratamiento farmacológico , Lesiones de la Cornea/etiología , Extractos Vegetales/uso terapéutico , Pterigion/complicaciones , Pterigion/cirugía , Animales , Cortisona/farmacología , Cortisona/uso terapéutico , Curcuma/efectos adversos , Humanos , Extractos Vegetales/efectos adversos , Extractos Vegetales/farmacología , Cicatrización de Heridas/efectos de los fármacos
2.
Biomed Res Int ; 2017: 2956597, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29392130

RESUMEN

Pterygium is a relatively common eye disease that can display an aggressive clinical behaviour. To evaluate the in vitro effects of Curcuma longa on human pterygium-derived keratinocytes, specimens of pterygium from 20 patients undergoing pterygium surgical excision were collected. Pterygium explants were put into culture and derived keratinocytes were treated with an alcoholic extract of 1.3% Curcuma longa in 0.001% Benzalkonium Chloride for 3, 6, and 24 h. Cultured cells were examined for CAM5.2 (anti-cytokeratin antibody) and CD140 (anti-fibroblast transmembrane glycoprotein antibody) expression between 3th and 16th passage to assess cell homogeneity. TUNEL technique and Annexin-V/PI staining in flow cytometry were used to detect keratinocyte apoptosis. We showed that Curcuma longa exerts a proapoptotic effect on pterygium-derived keratinocytes already after 3 h treatment. Moreover, after 24 h treatment, Curcuma longa induces a significant increase in TUNEL as well as Annexin-V/PI positive cells in comparison to untreated samples. Our study confirms previous observations highlighting the expression, in pterygium keratinocytes, of nuclear VEGF and gives evidence for the first time to the expression of nuclear and cytoplasmic VEGF-R1. All in all, these findings suggest that Curcuma longa could have some therapeutic potential in the treatment and prevention of human pterygium.


Asunto(s)
Curcuma/química , Queratinocitos/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Pterigion/tratamiento farmacológico , Apoptosis/efectos de los fármacos , Biomarcadores , Células Cultivadas , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Queratinocitos/patología , Queratinas/genética , Extractos Vegetales/química , Pterigion/patología , Receptor alfa de Factor de Crecimiento Derivado de Plaquetas/genética , Factor A de Crecimiento Endotelial Vascular/genética , Receptor 1 de Factores de Crecimiento Endotelial Vascular/genética
3.
Int J Oncol ; 22(1): 129-35, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12469195

RESUMEN

Murine erythroleukemia cells (Friend) respond to ionizing radiation with the activation and nuclear translocation of p85alpha subunit of phosphatidylinositol-3-kinase (PI-3-kinase) which mediates the downstream activation and nuclear translocation of atypical Protein kinase C zeta (PKC zeta). This event occurs mainly upon high dose of ionizing radiation (15 Gy) and is concomitant to an increase in BrdU incorporation, which probably accounts for a predominant repair DNA synthesis. Following treatment with wortmannin, a relatively specific inhibitor of PI-3-kinase, both an increased number of apoptotic cells and the inhibition of protein kinase C zeta translocation were detected. Altogether the evidence suggests a potential role of the PI-3-kinase/PKC zeta pathway in protecting Friend cells from ionizing radiation-induced apoptosis offering PKC zeta for consideration as possible target of pharmacological treatments.


Asunto(s)
Apoptosis/efectos de la radiación , Virus de la Leucemia Murina de Friend , Leucemia Eritroblástica Aguda/radioterapia , Fosfatidilinositol 3-Quinasas/fisiología , Proteína Quinasa C/fisiología , ADN/biosíntesis , Activación Enzimática , Humanos , Leucemia Eritroblástica Aguda/patología , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA